2-232130679-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_152383.5(DIS3L2):āc.662C>Gā(p.Thr221Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000756 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152383.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000923 AC: 23AN: 249118Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135154
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461670Hom.: 0 Cov.: 30 AF XY: 0.0000316 AC XY: 23AN XY: 727138
GnomAD4 genome AF: 0.000486 AC: 74AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74448
ClinVar
Submissions by phenotype
Perlman syndrome Uncertain:2Benign:1
- -
- -
- -
Inborn genetic diseases Uncertain:1
The c.662C>G (p.T221R) alteration is located in exon 7 (coding exon 6) of the DIS3L2 gene. This alteration results from a C to G substitution at nucleotide position 662, causing the threonine (T) at amino acid position 221 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at